Clinical Trial Update: Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy [NA]

View source ↗

Summary

Pilot study evaluating FIBRORESTIL® as an adjuvant intralesional treatment for Peyronie's disease in patients receiving standard therapy; the trial status is Ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• FIBRORESTIL®

Snippet

Sponsor: Lyx Institute | Conditions: Peyronie Disease | NA | Status: ACTIVE_NOT_RECRUITING